This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Dcprime B.v.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Amsterdam, NL (2018 - 2021)
- Leiden, NL (2021)
Company Filing History:
Years Active: 2018-2021
Title: Adriana Maria Kruisbeek: Innovator in Cancer Treatment
Introduction
Adriana Maria Kruisbeek is a prominent inventor based in Leiden, Netherlands. She has made significant contributions to the field of medical sciences, particularly in the development of innovative cancer treatments. With a total of 3 patents to her name, her work focuses on eliciting immune responses against tumors and improving therapeutic cancer vaccines.
Latest Patents
One of her latest patents is a combination product for use in tumor vaccination. This invention relates to a combination product designed to elicit an immune response against tumors in subjects. The product comprises an immunogenic composition that includes a non-human antigenic polypeptide or a nucleic acid encoding the immunogen, along with optional pharmaceutically-acceptable carriers, adjuvants, excipients, and/or diluents. Additionally, the invention provides fusion proteins and protein-protein conjugates that can be utilized in medical methods for cancer treatment.
Another significant patent involves therapeutic cancer vaccines derived from a novel dendritic cell line. This invention provides means and methods for treating cancer by developing fully functional dendritic cells that express cancer-specific antigens. The precursor cell line for dendritic cells, known as DC-One, was deposited at the DSMZ under accession number DSMZ ACC3189 on November 15, 2012.
Career Highlights
Adriana is currently associated with Dcprime B.V., where she continues her research and development efforts in cancer immunotherapy. Her innovative approaches have the potential to transform cancer treatment and improve patient outcomes.
Collaborations
Throughout her career, Adriana has collaborated with notable colleagues, including Sandra Van Wetering and Erik Hans Manting. These partnerships have further enhanced her research and contributed to the advancement of cancer therapies.
Conclusion
Adriana Maria Kruisbeek is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for new therapeutic approaches. Her dedication to improving patient care through scientific research is commendable and highlights the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile